Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2020

01-12-2020 | Carcinoid Tumor | Stanford Multidisciplinary Seminars

Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease

Authors: John R. Bergquist, Amy Y. Li, Edwina M. Chang, Gregory D. Scott, Monica M. Dua, Brendan C. Visser

Published in: Digestive Diseases and Sciences | Issue 12/2020

Login to get access

Excerpt

A 53-year-old woman was initially evaluated for abdominal discomfort and found to have bulky bilobar hepatic neuroendocrine tumor with unidentified primary. Biopsy of a liver lesion revealed well-differentiated neuroendocrine tumor, WHO G1, Ki-67 2% with mitotic rate 1/mm2. Since her tumor progressed during initial treatment with octreotide depot injections, she was switched to capecitabine/temozolomide, but again slowly progressed. After discussion in a multidisciplinary neuroendocrine tumor board, the decision was made to proceed with surgical resection. Her preoperative imaging (Fig. 1) showed bilobar disease with dominant masses abutting the right and left hepatic pedicles as well as the right and middle hepatic veins with the left hepatic vein free of tumor.
Literature
3.
go back to reference Shah H, Benson AB, Lurie RH, et al. NCCN Guidelines Version 1.2019 Neuroendocrine and Adrenal Tumors; 2019. Shah H, Benson AB, Lurie RH, et al. NCCN Guidelines Version 1.2019 Neuroendocrine and Adrenal Tumors; 2019.
Metadata
Title
Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease
Authors
John R. Bergquist
Amy Y. Li
Edwina M. Chang
Gregory D. Scott
Monica M. Dua
Brendan C. Visser
Publication date
01-12-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06257-8

Other articles of this Issue 12/2020

Digestive Diseases and Sciences 12/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.